Pacific Biosciences Of California Gross Profit 2010-2024 | PACB
Pacific Biosciences Of California Annual Gross Profit (Millions of US $) |
|
---|---|
2023 | $53 |
2022 | $49 |
2021 | $59 |
2020 | $33 |
2019 | $35 |
2018 | $25 |
2017 | $35 |
2016 | $44 |
2015 | $53 |
2014 | $23 |
2013 | $6 |
2012 | $1 |
2011 | $13 |
2010 | $2 |
2009 | $0 |
Pacific Biosciences Of California Quarterly Gross Profit (Millions of US $) |
|
---|---|
2024-09-30 | $10 |
2024-06-30 | $6 |
2024-03-31 | $11 |
2023-12-31 | $10 |
2023-09-30 | $18 |
2023-06-30 | $16 |
2023-03-31 | $10 |
2022-12-31 | $5 |
2022-09-30 | $14 |
2022-06-30 | $16 |
2022-03-31 | $14 |
2021-12-31 | $17 |
2021-09-30 | $15 |
2021-06-30 | $14 |
2021-03-31 | $13 |
2020-12-31 | $11 |
2020-09-30 | $7 |
2020-06-30 | $7 |
2020-03-31 | $7 |
2019-12-31 | $13 |
2019-09-30 | $7 |
2019-06-30 | $10 |
2019-03-31 | $5 |
2018-12-31 | $6 |
2018-09-30 | $3 |
2018-06-30 | $9 |
2018-03-31 | $7 |
2017-12-31 | $9 |
2017-09-30 | $8 |
2017-06-30 | $8 |
2017-03-31 | $9 |
2016-12-31 | $11 |
2016-09-30 | $13 |
2016-06-30 | $11 |
2016-03-31 | $10 |
2015-12-31 | $26 |
2015-09-30 | $7 |
2015-06-30 | $15 |
2015-03-31 | $6 |
2014-12-31 | $4 |
2014-09-30 | $13 |
2014-06-30 | $3 |
2014-03-31 | $3 |
2013-12-31 | $3 |
2013-09-30 | $1 |
2013-06-30 | $1 |
2013-03-31 | $1 |
2012-12-31 | $1 |
2012-09-30 | $0 |
2012-06-30 | $0 |
2012-03-31 | $-0 |
2011-12-31 | $2 |
2011-09-30 | $3 |
2011-06-30 | $8 |
2011-03-31 | $0 |
2010-12-31 | $0 |
2010-09-30 | $0 |
2010-06-30 | $1 |
2010-03-31 | $1 |
2009-12-31 | |
2009-09-30 |
Sector | Industry | Market Cap | Revenue |
---|---|---|---|
Medical | Medical Instruments Manufacturing | $0.501B | $0.201B |
Pacific Biosciences of California Inc., popularly known as PacBio, develops, manufactures and markets sequencing systems, which help in studying synthesis, composition, structure and regulation of deoxyribonucleic acid, popularly known as DNA. PacBio's products are based on Single Molecule, Real-Time (SMRT) technology. SMRT generates long reads that help in assembling a whole human genome from scratch, without using an existing reference genome as a template. This process is known as de novo assembly. To observe DNA replication process smoothly, PacBio offers the SMRT Cell, Phospholinked nucleotides and The PacBio RS II System. The PacBio RS II System includes the PacBio RS II instrument, consumables and software. PacBio launched its new Sequel system based on SMRT technology. PacBio deferred the gain from the Reverse Termination Fee from Illumina until the date when the associated contingency was resolved. |
Stock Name | Country | Market Cap | PE Ratio |
---|---|---|---|
Thermo Fisher Scientific (TMO) | United States | $204.416B | 24.94 |
Intuitive Surgical (ISRG) | United States | $192.946B | 100.88 |
Alcon (ALC) | Switzerland | $43.080B | 28.83 |
Edwards Lifesciences (EW) | United States | $41.404B | 26.29 |
IQVIA Holdings (IQV) | United States | $36.405B | 20.06 |
IDEXX Laboratories (IDXX) | United States | $35.383B | 41.67 |
DexCom (DXCM) | United States | $31.603B | 47.59 |
Waters (WAT) | United States | $22.979B | 33.98 |
STERIS (STE) | Ireland | $21.385B | 24.62 |
SONOVA HOLDING (SONVY) | Switzerland | $19.978B | 0.00 |
Hologic (HOLX) | United States | $17.581B | 18.99 |
Fresenius Medical Care AG KGaA (FMS) | Germany | $13.691B | 14.05 |
Sysmex ADR (SSMXY) | Japan | $13.362B | 41.90 |
Globus Medical (GMED) | United States | $11.588B | 29.34 |
Penumbra (PEN) | United States | $9.412B | 92.19 |
Masimo (MASI) | United States | $9.326B | 45.13 |
Teleflex (TFX) | United States | $8.737B | 13.94 |
Glaukos (GKOS) | United States | $7.499B | 0.00 |
PROCEPT BioRobotics (PRCT) | United States | $5.035B | 0.00 |
Integer Holdings (ITGR) | United States | $4.735B | 26.84 |
Veracyte (VCYT) | United States | $3.384B | 101.54 |
Inari Medical (NARI) | United States | $3.018B | 0.00 |
LivaNova (LIVN) | United Kingdom | $2.803B | 16.18 |
Nihon Kohden (NHNKY) | Japan | $2.421B | 18.39 |
TransMedics (TMDX) | United States | $2.398B | 76.00 |
Tandem Diabetes Care (TNDM) | United States | $2.192B | 0.00 |
Elekta AB (EKTAY) | Sweden | $2.121B | 19.07 |
Integra LifeSciences Holdings (IART) | United States | $1.901B | 9.93 |
RxSight (RXST) | United States | $1.756B | 0.00 |
Alphatec Holdings (ATEC) | United States | $1.418B | 0.00 |
Pulse Biosciences (PLSE) | United States | $1.248B | 0.00 |
Artivion (AORT) | United States | $1.244B | 82.44 |
OPKO Health (OPK) | United States | $1.078B | 0.00 |
AVANOS MEDICAL, INC (AVNS) | United States | $0.875B | 14.87 |
Paragon 28 (FNA) | United States | $0.856B | 0.00 |
ORTHOFIX MEDICAL INC (OFIX) | United States | $0.739B | 0.00 |
IRadimed (IRMD) | United States | $0.680B | 36.74 |
Mesa Laboratories (MLAB) | United States | $0.668B | 15.75 |
AxoGen (AXGN) | United States | $0.635B | 0.00 |
OrthoPediatrics (KIDS) | United States | $0.634B | 0.00 |
SiBone (SIBN) | United States | $0.546B | 0.00 |
Treace Medical Concepts (TMCI) | United States | $0.533B | 0.00 |
Semler Scientific (SMLR) | United States | $0.527B | 31.04 |
Tactile Systems Technology (TCMD) | United States | $0.453B | 24.53 |
Delcath Systems (DCTH) | United States | $0.379B | 0.00 |
CVRx (CVRX) | United States | $0.365B | 0.00 |
NeuroPace (NPCE) | United States | $0.356B | 0.00 |
ClearPoint Neuro (CLPT) | United States | $0.331B | 0.00 |
AngioDynamics (ANGO) | United States | $0.289B | 0.00 |
Inogen (INGN) | United States | $0.237B | 0.00 |
Accuray (ARAY) | United States | $0.211B | 0.00 |
Alpha Tau Medical (DRTS) | Israel | $0.210B | 0.00 |
Sight Sciences (SGHT) | United States | $0.196B | 0.00 |
KORU Medical Systems (KRMD) | United States | $0.182B | 0.00 |
Nevro (NVRO) | United States | $0.160B | 0.00 |
Atossa Genetics (ATOS) | United States | $0.155B | 0.00 |
Sensus Healthcare (SRTS) | United States | $0.141B | 15.05 |
Spectral Diagnostics (EDTXF) | Canada | $0.116B | 0.00 |
908 Devices (MASS) | United States | $0.092B | 0.00 |
EDAP TMS S.A (EDAP) | France | $0.091B | 0.00 |
LENSAR (LNSR) | United States | $0.089B | 0.00 |
Vicarious Surgical (RBOT) | United States | $0.088B | 0.00 |
WORK Medical Technology Group (WOK) | China | $0.087B | 0.00 |
Monogram Orthopaedics (MGRM) | United States | $0.080B | 0.00 |
InspireMD (NSPR) | Israel | $0.079B | 0.00 |
Covalon Technologies (CVALF) | Canada | $0.074B | 0.00 |
Hyperfine (HYPR) | United States | $0.073B | 0.00 |
Lucid Diagnostics (LUCD) | United States | $0.057B | 0.00 |
EnVVeno Medical (NVNO) | United States | $0.053B | 0.00 |
Rapid Micro Biosystems (RPID) | United States | $0.045B | 0.00 |
Envoy Medical (COCH) | United States | $0.044B | 0.00 |
Spectral AI (MDAI) | United States | $0.041B | 0.00 |
Accelerate Diagnostics (AXDX) | United States | $0.039B | 0.00 |
Adagio Medical Holdings (ADGM) | United States | $0.036B | 0.00 |
Neuronetics (STIM) | United States | $0.035B | 0.00 |
Precision Optics (POCI) | United States | $0.032B | 0.00 |
Biosig Technologies (BSGM) | United States | $0.029B | 0.00 |
DarioHealth (DRIO) | United States | $0.026B | 0.00 |
NexGel (NXGL) | United States | $0.024B | 0.00 |
Microbot Medical (MBOT) | United States | $0.017B | 0.00 |
Inspira Technologies OXY B.H.N (IINN) | Israel | $0.017B | 0.00 |
Ekso Bionics Holdings (EKSO) | United States | $0.015B | 0.00 |
Baird Medical Investment Holdings (BDMD) | $0.015B | 0.00 | |
Aspira Women's Health (AWH) | United States | $0.014B | 0.00 |
PAVmed (PAVM) | United States | $0.013B | 0.00 |
T2 Biosystems (TTOO) | United States | $0.011B | 0.00 |
QT Imaging Holdings (QTI) | United States | $0.010B | 0.00 |
Tenon Medical (TNON) | United States | $0.007B | 0.00 |
Nuwellis (NUWE) | United States | $0.006B | 0.00 |
SINTX TECHNOLOGIES, INC (SINT) | United States | $0.005B | 0.00 |
Check-Cap (CHEK) | Israel | $0.005B | 0.00 |
Autonomix Medical (AMIX) | United States | $0.005B | 0.00 |
ReShape Lifesciences (RSLS) | United States | $0.004B | 0.00 |
Nanovibronix (NAOV) | United States | $0.003B | 0.00 |
ENDRA Life Sciences (NDRA) | United States | $0.003B | 0.00 |
Avinger (AVGR) | United States | $0.003B | 0.00 |
Helius Medical Technologies (HSDT) | United States | $0.002B | 0.00 |
Venus Concept (VERO) | Canada | $0.002B | 0.00 |
Bluejay Diagnostics (BJDX) | United States | $0.002B | 0.00 |
Longview Acquisition II (LGV) | United States | $0.000B | 0.00 |
Spinal Elements Holdings (SPEL) | United States | $0.000B | 0.00 |